Pills
to Reduce Weight
|
Clinical Weight Loss Trials of Diet PillsDiet Pills Trial - Sibutramine/Meridia Drug - Health & SafetyAn assessment of the safety and efficacy of sibutramine (brand name Meridia), an anti-obesity drug with a novel mechanism of action. Sibutramine/Meridia is a combined serotonin(5-HT) and noradrenaline (NA)re-uptake inhibitor. Sibutramine/Meridia works predominantly through its two pharmacologically active metabolites (i.e. primary and secondary amines) which induce marked weight loss by affecting both food intake and energy expenditure. It is able to enhance the physiological process of satiety, and to stimulate thermogenesis, increasing the efferent sympathetic activity to thermogenically active brown fat. There is a dose-related reduction in body weight in clinical trials with sibutramine, with weight loss up to 11 percent below baseline, which can last up to 18 months with continued treatment. When weight loss is induced with a very low calorie diet (VLCDL), patients randomized to the sibutramine/Meridia treatment continued to lose weight over a 1 year period, reaching 15 percent below baseline, whereas the placebo-treated patients regained some weight. Sibutramine/Meridia improves metabolic fitness, by decreasing the biochemical risk factors associated with obesity, such as plasma triglycerides, total cholesterol and low density lipoprotein (LDL) cholesterol, glucose and insulin, and increasing HDL-cholesterol. In controlled studies, 84 percent of sibutramine-treated patients reported side effects, most commonly including dry mouth, constipation and insomnia, compared with 71 percent of patients receiving placebo. A small increase in heart rate and blood pressure also occurs and persists for as long as treatment is continued, which, therefore, requires monitoring. Nevertheless, successful treatment of moderately hypertensive obese patients with sibutramine/Meridia has been demonstrated without undue blood pressure problems and even a mean lowering of blood pressure associated with weight loss. Finally, sibutramine/Meridia does not have the potential for abuse that is characteristic of amphetamine and it is indistinguishable from placebo in abuse potential studies. Source: Nisoli E, Carruba MO. Center for Study and Research on Obesity, Department of Preclinical Sciences, School of Medicine, University of Milan, LITA Vialba, L. Sacco Hospital, via G.B. Grassi, 74, Milan 20157, Italy. 2002 Some Clinical Weight Loss Trials of Diet PillsXenical
Diet Pills and Diabesity --------------------------------------------------------------------- Information About Obesity Drugs and Weight Loss Supplements |
Prescription |
Reviews of Obesity Medications and Diet SupplementsThis web site provides only general advice on popular weight loss pills and dietary supplements. Under no circumstances should this information be used as a substitute for professional medical advice. Before taking any diet or weight loss pills, we recommend that you seek advice from your doctor. Only your doctor can safely advise you about which drugs or supplements are best for you.© 2006. Diet-Pills-Information. All rights reserved. |